I-cell disease

I-cell disease
I-cell disease
Classification and external resources

Mannose-6-phosphate (M6P). I-cell disease involves a failure to add M6P to proteins.
ICD-10 E77.0
ICD-9 272.7
OMIM 252500
DiseasesDB 29175
eMedicine ped/1150
MeSH D009081

Inclusion-cell (I-cell) disease, also referred to as mucolipidosis II (ML II),[1][2] is part of the lysosomal storage disease family and results from a defective phosphotransferase (an enzyme of the Golgi apparatus). This enzyme transfers phosphate to mannose residues on specific proteins, and serves as a marker for them to be targeted to lysozomes within the cell. Without this marker, the proteins are instead excreted outside the cell -- the default pathway for proteins moving through the Golgi apparatus. Lysozomes cannot function without these proteins, which function as catabolic enzymes for the normal breakdown of substances throughout the body. As a result, a build up of these substances occurs within lysosomes because they cannot be degraded, resulting in the characteristic "I cells," or "inclusion cells." These cells can be identified under the microscope. In addition, the defective lysozomal enzymes normally found only within lysozomes are instead found in high concentrations in the blood.

Contents

Presentation

ML II is a particularly severe form of ML that resembles one of the mucopolysaccharidoses called Hurler syndrome. Typically, by the age of 6 months, failure to thrive and developmental delays are obvious symptoms of this disorder. Some physical signs, such as abnormal skeletal development, coarse facial features, and restricted joint movement, may be present at birth. Children with ML II usually have enlargement of certain organs, such as the liver (hepatomegaly) or spleen (splenomegaly), and sometimes even the heart valves. Affected children often have stiff claw-shaped hands and fail to grow and develop in the first months of life. Delays in the development of their motor skills are usually more pronounced than delays in their cognitive (mental processing) skills. Children with ML II eventually develop a clouding on the cornea of their eyes and, because of their lack of growth, develop short-trunk dwarfism (underdeveloped trunk). These young patients are often plagued by recurrent respiratory tract infections, including pneumonia, otitis media (middle ear infections), bronchitis and carpal tunnel syndrome. Children with ML II generally die before their seventh year of life, often as a result of congestive heart failure or recurrent respiratory tract infections.

Pathophysiology

I-cell disease is an autosomal recessive disorder caused by a deficiency of GlcNAc phosphotransferase, which phosphorylates mannose residues to mannose-6-phosphate on N-linked glycoproteins in the Golgi apparatus within the cell. Without mannose-6-phosphate to target them to the lysosomes, the enzymes are transported from the Golgi to the extracellular space, resulting in large intracellular inclusions of molecules requiring lysosomal degradation in patients with the disease (hence the name of the disorder).[3] Hydrolases secreted into the blood stream cause little problem as they are deactivated in the neutral pH of the blood.

It can be associated with GNPTA.[4] In a case report, it was complicated by severe dilative cardiomyopathy(DCM)[5]

Treatment

There is no cure yet for I-Cell disease/Mucolipidosis II disease. Treatment is limited to controlling or reducing the symptoms that are associated with this disorder. Nutrition supplements, particularly iron and vitamin B12, are often recommended for individuals with I-Cell disease. Physical therapy to improve motor delays and speech therapy to improve language acquisition are treatment options. Surgery can remove the thin layer of corneal clouding to temporarily improve the complication. It is possible that bone marrow transplant may be helpful in delaying or correcting the neurological deterioration that occurs with I-Cell disease.[1]

See also

References

  1. ^ "mucolipidosis II" at Dorland's Medical Dictionary
  2. ^ Plante M, Claveau S, Lepage P et al. (March 2008). "Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population". Clin. Genet. 73 (3): 236–44. doi:10.1111/j.1399-0004.2007.00954.x. PMID 18190596. http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=0009-9163&date=2008&volume=73&issue=3&spage=236. 
  3. ^ Champe, Pamela (2004). Lippincott's Illutrated Reviews: Biochemistry. Richard A Harvey, Denise R Ferrier (3rd ed.). Philadelphia, Pa.: Lippincott-Raven. p. 167. ISBN 0781722659. 
  4. ^ Tiede S, Storch S, Lübke T et al. (2005). "Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase". Nat. Med. 11 (10): 1109–12. doi:10.1038/nm1305. PMID 16200072. 
  5. ^ http://www.sahha.gov.mt/pages.aspx?page=752

External links


Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • Sickle-cell disease — This article is about the disease itself. For the genetic transmission of sickle cell disease and its carrier state, see sickle cell trait. Sickle cell disease Classification and external resources Normal and sickle shaped red blood cells ICD 10 …   Wikipedia

  • Sickle cell disease — A genetic blood disease due to the presence of an abnormal form of hemoglobin, namely hemoglobin S. Hemoglobin is the molecule in red blood cells that transports oxygen from the lungs to the farthest reaches of the body. Sickle cell disease, also …   Medical dictionary

  • sickle-cell disease — noun a congenital form of anemia occurring mostly in blacks; characterized by abnormal blood cells having a crescent shape • Syn: ↑sickle cell anemia, ↑sickle cell anaemia, ↑crescent cell anemia, ↑crescent cell anaemia, ↑drepanocytic anemia,… …   Useful english dictionary

  • sickle-cell disease — n SICKLE CELL ANEMIA * * * a hereditary blood disease that mainly affects people of African ancestry but also occurs in the Mediterranean region and reaches high frequencies in parts of Saudi Arabia and India. It occurs when the sickle cell gene… …   Medical dictionary

  • sickle cell disease — An inherited disease in which the red blood cells have an abnormal crescent shape, block small blood vessels, and do not last as long as normal red blood cells. Sickle cell disease is caused by a mutation (change) in one of the genes for… …   English dictionary of cancer terms

  • I-cell disease — “I cell” disease. См. муколипидоз II типа. (Источник: «Англо русский толковый словарь генетических терминов». Арефьев В.А., Лисовенко Л.А., Москва: Изд во ВНИРО, 1995 г.) …   Молекулярная биология и генетика. Толковый словарь.

  • Paget cell disease necrosis test — Pag·et cell, disease, necrosis, test (pajґət) [Sir James Paget, English surgeon, 1814–1899] see under cell, disease, necrosis, and test …   Medical dictionary

  • sickle-cell disease — noun A disease characterized by sickle shaped red blood cells. Syn: sickle cell anaemia, sickle cell anaemia, sickle cell anemia …   Wiktionary

  • sickle-cell disease — drepanocytosis a hereditary blood disease that mainly affects people of African ancestry but also occurs in the Mediterranean region and reaches high frequencies in parts of Saudi Arabia and India. It occurs when the sickle cell gene has been… …   The new mediacal dictionary

  • sickle-cell disease — noun see sickle cell anemia …   New Collegiate Dictionary

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”